Osteonecrosis of the jaw after zoledronic Acid and denosumab treatment.

Fusco V, Galassi C, Berruti A, Ciuffreda L, Ortega C, Ciccone G, Angeli A, Bertetto O.

J Clin Oncol 2011; 29: e521-2; author reply e523-4.

http://www.ncbi.nlm.nih.gov/pubmed/21537047